Elixinol Wellness Limited
Elixinol Wellness Limited
Your view on EXL.AX
Overview
What the company does, where it operates, and who runs it.
About Elixinol Wellness Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Natalie Butler
- Headquarters
- 51 - 53 Riversdale Road, Newtown, VIC, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Natalie Butler
- Headquarters
- 51 - 53 Riversdale Road, Newtown, VIC, AU
Elixinol Wellness Limited, an entity established in 2017 and headquartered in Sydney, Australia, operates internationally through its subsidiaries. The company is primarily involved in the manufacturing and global distribution of a wide array of hemp-derived products, encompassing nutraceuticals, cosmetics, and various food items.
These products are marketed under its distinct brands, Elixinol and Hemp Foods Australia, reaching consumers across the Americas, Europe, and Australia. Its extensive product range features hemp-derived cannabidiol (CBD) items, food products, dietary supplements, and topical skincare solutions.
Notably, the company transitioned to its current name in May 2021, having previously been known as Elixinol Global Limited.
Past Reports
Historical coverage archive.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Elixinol Wellness Limited. Starting points for Elixinol Wellness Limited: EPS -AUD 0.0084, beta 2.18 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Elixinol Wellness Limited. Elixinol Wellness Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Elixinol Wellness Limited. Trailing twelve-month EPS for Elixinol Wellness Limited stands at -AUD 0.0084. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Elixinol Wellness Limited. Elixinol Wellness Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 1AD.AXAdAlta Limited | Healthcare | Biotechnology | — | ||
| ANR.AXAnatara Lifesciences Ltd | Healthcare | Biotechnology | — | ||
| CAN.AXCann Group Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| CTQ.AXCareteq Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IBX.AXImagion Biosystems Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IVX.AXInvion Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| OAK.AXOakridge International Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| OSX.AXOsteopore Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBDHFHempfusion Wellness Inc. | Healthcare | OTC | $1,635 | ||
| CBDLCBD Life Sciences Inc. | Healthcare | OTC | $375,394 | ||
| CBDXCurative Biosciences, Inc. | Healthcare | OTC | $51,578 | ||
| CBDYTarget Group Inc. | Healthcare | OTC | $863,836 | ||
| CBGLCannabis Global, Inc. | Healthcare | OTC | $28,410 | ||
| CBIHCannabis Bioscience International Holdings, Inc. | Healthcare | OTC | $5.2M | ||
| CBSTFThe Cannabist Company Holdings Inc. | Healthcare | NYSE | $14.5M | ||
| CBWTFAuxly Cannabis Group Inc. | Healthcare | OTC | $121.4M | ||
| CDVA.CNCordovaCann Corp. | Healthcare | CNQ | $4.1M | ||
| CENBFCEN Biotech, Inc. | Healthcare | OTC | $6,526 | ||
| CGCCanopy Growth Corporation | Healthcare | NASDAQ | $212.3M | ||
| CHALFChalice Brands Ltd. | Healthcare | OTC | $6,660 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Elixinol Wellness Limited.